| 1 |
32704173 | Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinoma. | 2020 Oct |
1 |
| 2 |
29755672 | Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma. | 2018 Apr 17 |
1 |
| 3 |
23012246 | RSK2(Ser227) at N-terminal kinase domain is a potential therapeutic target for multiple myeloma. | 2012 Dec |
1 |
| 4 |
21658626 | New agents in follicular lymphoma. | 2011 Jun |
1 |
| 5 |
21825263 | Phase I trial of lenalidomide and CCI-779 in patients with relapsed multiple myeloma: evidence for lenalidomide-CCI-779 interaction via P-glycoprotein. | 2011 Sep 1 |
1 |